Xvivo Perfusion AB (publ) (0RKL.L)
SEK 461.69
(1.25%)
SEK 461.69
(1.25%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 38.5 Million SEK | 66.11% |
| 2022 | 23.18 Million SEK | 232.01% |
| 2021 | 6.98 Million SEK | 120.35% |
| 2020 | -34.31 Million SEK | -709.14% |
| 2019 | 5.63 Million SEK | -59.76% |
| 2018 | 14 Million SEK | 97.02% |
| 2017 | 7.1 Million SEK | 159.91% |
| 2016 | 2.73 Million SEK | -62.09% |
| 2015 | 7.21 Million SEK | 7.83% |
| 2014 | 6.68 Million SEK | -37.92% |
| 2013 | 10.77 Million SEK | 4982.08% |
| 2012 | 212 Thousand SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 20.47 Million SEK | -38.75% |
| 2024 Q1 | 18.99 Million SEK | 175.49% |
| 2024 Q2 | 33.42 Million SEK | 75.99% |
| 2023 Q4 | -25.16 Million SEK | -574.56% |
| 2023 Q3 | 5.3 Million SEK | 39.45% |
| 2023 Q2 | 3.8 Million SEK | -66.07% |
| 2023 FY | 38.5 Million SEK | 66.11% |
| 2023 Q1 | 11.2 Million SEK | 386.41% |
| 2022 Q2 | -8.35 Million SEK | -658.9% |
| 2022 FY | 23.18 Million SEK | 232.01% |
| 2022 Q4 | 2.3 Million SEK | 149.47% |
| 2022 Q3 | -4.65 Million SEK | 44.23% |
| 2022 Q1 | 1.49 Million SEK | 118.0% |
| 2021 Q4 | -8.3 Million SEK | -105.9% |
| 2021 FY | 6.98 Million SEK | 120.35% |
| 2021 Q3 | -4.03 Million SEK | 56.89% |
| 2021 Q2 | -9.35 Million SEK | -393.75% |
| 2021 Q1 | 3.18 Million SEK | 122.22% |
| 2020 FY | -34.31 Million SEK | -709.14% |
| 2020 Q4 | -14.32 Million SEK | 23.22% |
| 2020 Q3 | -18.66 Million SEK | -46.83% |
| 2020 Q2 | -12.7 Million SEK | -55356.52% |
| 2020 Q1 | 23 Thousand SEK | -98.56% |
| 2019 Q2 | 1.92 Million SEK | 203.6% |
| 2019 Q3 | 2.27 Million SEK | 18.04% |
| 2019 Q4 | 1.59 Million SEK | -29.91% |
| 2019 FY | 5.63 Million SEK | -59.76% |
| 2019 Q1 | -1.86 Million SEK | -130.45% |
| 2018 FY | 14 Million SEK | 97.02% |
| 2018 Q4 | 6.11 Million SEK | 728.46% |
| 2018 Q3 | 738 Thousand SEK | -81.55% |
| 2018 Q2 | 3.99 Million SEK | 26.99% |
| 2018 Q1 | 3.14 Million SEK | -33.55% |
| 2017 Q1 | 13 Thousand SEK | -50.0% |
| 2017 Q2 | 1.96 Million SEK | 15015.38% |
| 2017 Q4 | 4.73 Million SEK | 1118.25% |
| 2017 FY | 7.1 Million SEK | 159.91% |
| 2017 Q3 | 389 Thousand SEK | -80.2% |
| 2016 Q2 | 1.66 Million SEK | -6.31% |
| 2016 Q3 | -732 Thousand SEK | -143.99% |
| 2016 Q4 | 26 Thousand SEK | 103.55% |
| 2016 FY | 2.73 Million SEK | -62.09% |
| 2016 Q1 | 1.77 Million SEK | -59.59% |
| 2015 Q2 | 1.49 Million SEK | 10086.67% |
| 2015 Q4 | 4.39 Million SEK | 229.46% |
| 2015 Q3 | 1.33 Million SEK | -10.95% |
| 2015 Q1 | -15 Thousand SEK | -105.02% |
| 2015 FY | 7.21 Million SEK | 7.83% |
| 2014 Q1 | 2.73 Million SEK | 4.62% |
| 2014 FY | 6.68 Million SEK | -37.92% |
| 2014 Q2 | 1.38 Million SEK | -49.31% |
| 2014 Q3 | 2.26 Million SEK | 63.04% |
| 2014 Q4 | 299 Thousand SEK | -86.79% |
| 2013 Q2 | 2 Million SEK | -42.14% |
| 2013 Q3 | 2.69 Million SEK | 34.4% |
| 2013 FY | 10.77 Million SEK | 4982.08% |
| 2013 Q4 | 2.61 Million SEK | -2.79% |
| 2013 Q1 | 3.46 Million SEK | 1533.02% |
| 2012 Q4 | 212 Thousand SEK | 0.0% |
| 2012 FY | 212 Thousand SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|